EUVIMEDEUVIMED entdecken
Crossref

Sonoactivated Z‐Scheme Heterojunction for Enhanced Sonodynamic Mitophagy Inhibition and Triple Negative Breast Cancer Treatment

Yi Zheng, Tianhu Zhang, Meiqi Chang, Lili Xia, Liang Chen, Li Ding, Yu Chen iD, Rong Wu

Advanced Materials · 2025

DOI: 10.1002/adma.202413601 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Materials, 2025. Verfasst von Yi Zheng und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ultrasound, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200080, P. R. China. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Mitophagy, Ultrasonic Therapy, Antineoplastic Agents. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Shanghai Science and Technology Program, Basic Research Program of Shanghai Municipal Government.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sonodynamic therapy (SDT) has emerged as a potent therapeutic modality to generate intratumoral toxic reactive oxygen species (ROS) in combating refractory triple‐negative breast cancer (TNBC). However, its therapeutic efficacy is compromised due to pro‐survival cancer‐cell mitophagy to mitigate mitochondrial oxidative damage. Here, an “all‐in‐one” tumor‐therapeutic strategy that integrates nanosonosensitizer‐augmented noninvasive SDT with mitophagy inhibition is reported. This is achieved using a rationally constructed sonoactivated liquid Z‐scheme heterojunction that connects sonosensitizer PtCu 3 nanocages and mitophagy‐blocking sonosensitizer BP nanosheets via an amphipathic organic linker (PEI‐PEG 5000 ‐C18). The conjugated electron mediator (M, Cp*Rh(phen)Cl) is strategically positioned between the 2 sonosensitizers to facilitate electron transfer. This M‐based Z‐scheme configuration prolongs the separation of sonoactivated electron‐hole pairs, leading to efficient ROS generation upon ultrasound stimulation. Importantly, Cu 2+ released from PtCu 3 expedites BP degradation by reducing phosphorus vacancy formation energy, improving the overall biodegradability of BP‐M‐PtCu 3 and favoring phosphate ions production. These ions elevate lysosomal pH, inhibiting the hydrolysis of damaged mitochondria within autophagic lysosomes, thus preventing cancer cell self‐preservation under oxidative stress and effectively eliminating TNBC. It is believe that the M‐based sonoactivated Z‐scheme heterojunction will be a promising sonosensitizer structure, and the sonodynamic mitophagy inhibition strategy offers valuable prospects for cancer treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Triple Negative Breast NeoplasmsMitophagyUltrasonic TherapyAntineoplastic AgentsHumansCell Line, TumorReactive Oxygen SpeciesAnimalsFemaleMiceCopper

Stichwörter der Autor:innen

cancer therapyliquid Z‐scheme heterojunctionmitophagy inhibitionnanomedicinesonodynamic therapy

Substanzen

Reactive Oxygen SpeciesCopperAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Ultrasound, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200080, P. R. China.
  • Central Laboratory of Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 200071, P. R. China.
  • Materdicine Lab, School of Life Sciences, Shanghai University, Shanghai, 200444, P. R. China.
  • Department of Medical Ultrasound, National Clinical Research Center of Interventional Medicine, Shanghai Tenth People's Hospital, Tongji University Cancer Center, Tongji University School of Medicine, Tongji University,…

ORCID-Profile: Yu Chen

Förderung

  • National Natural Science Foundation of China
  • Shanghai Science and Technology Program
  • Basic Research Program of Shanghai Municipal Government
  • National Key Research and Development
  • Science and Technology Commission of Shanghai Municipality

Zitieren

APA

Zheng, Y., Zhang, T., Chang, M., Xia, L., Chen, L., Ding, L., Chen, Y., & Wu, R. (2025). Sonoactivated Z‐Scheme Heterojunction for Enhanced Sonodynamic Mitophagy Inhibition and Triple Negative Breast Cancer Treatment. Advanced Materials. https://doi.org/10.1002/adma.202413601

Vancouver

Zheng Y, Zhang T, Chang M, Xia L, Chen L, Ding L, et al. Sonoactivated Z‐Scheme Heterojunction for Enhanced Sonodynamic Mitophagy Inhibition and Triple Negative Breast Cancer Treatment. Advanced Materials. 2025. doi:10.1002/adma.202413601

BibTeX
@article{Zheng2025,
  author = {Zheng, Yi and Zhang, Tianhu and Chang, Meiqi and Xia, Lili and Chen, Liang and Ding, Li and Chen, Yu and Wu, Rong},
  title = {Sonoactivated Z‐Scheme Heterojunction for Enhanced Sonodynamic Mitophagy Inhibition and Triple Negative Breast Cancer Treatment},
  journal = {Advanced Materials},
  year = {2025},
  doi = {10.1002/adma.202413601}
}
Kostenlos starten →